Word

CURA

Status

Dead

Status Code

606

Status Date

Monday, July 3, 2023

Serial Number

87836345

Mark Type

4000

Filing Date

Thursday, March 15, 2018

Published for Opposition

Tuesday, April 7, 2020

Abandoned Date

Monday, July 3, 2023

Trademark Owner History

KEYAMED NA INC. - 1st New Owner After Publication
CuraCloud Corporation - Owner At Publication

Classifications

9 Computer software for use in medical diagnostics using medical image analysis, medical records analysis, and bioinformatics analysis supporting clinicians and researchers in fields of radiology, cardiology, oncology, pulmonology, neurology, hematology, endocrinology, otolaryngology, gynecology, obstetrics, urology, orthopedics, ophthalmology, pathology, pediatrics, physical medicine, surgery, emergency medicine, medical genetics and genomics, dermatology, family medicine, internal medicine, colorectal medicine, psychiatry, allergy and immunology, and preventive medicine; computer software for the analysis of medical data, namely, genomics data, for use in identifying and predicting actionable biomarkers, neoantigens, and molecular data for developing paired diagnostics and therapeutics in the fields of radiology, cardiology, oncology, pulmonology, neurology, hematology, endocrinology, otolaryngology, gynecology, obstetrics, urology, orthopedics, ophthalmology, pathology, pediatrics, physical medicine, surgery, emergency medicine, medical genetics and genomics, dermatology, family medicine, internal medicine, colorectal medicine, psychiatry, allergy and immunology, and preventive medicine; computer software for executing preconfigured non-field specific machine learning and deep learning algorithms and processes for the purposes of uploading and managing data for the training of preconfigured data models implemented on a hosted software platform utilizing said machine learning and deep learning processes and for utilizing said trained data models for use in medical diagnostics, medical image analysis, medical screening, medical testing, DNA screening for medical purposes, and genetic testing for medical purposes; computer software for conducting natural language processing on medical records to transform unstructured data into structured data supporting clinical and research use; computer software for detecting and predicting neoantigens and peptides for immunotherapy development

44 Performing medical testing for diagnostic purposes, in particular for diagnostic imaging, including x- rays, computed tomography, magnetic resonance imaging (MRI) and other modalities; performing medical testing on tissue samples and body fluids for the detection of genetic and genomic information pertaining to human disease for medical diagnostic or treatment purposes; providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services and medical testing for diagnostic or treatment purposes of radiology, cardiology, oncology, pulmonology, neurology, hematology, endocrinology, otolaryngology, gynecology, obstetrics, urology, orthopedics, ophthalmology, pathology, pediatrics, physical medicine, surgery, emergency medicine, medical genetics, dermatology, family medicine, internal medicine, colorectal medicine, psychiatry, allergy and immunology, and preventive medicine

42 Providing software as a service (SaaS) services featuring software for use in medical diagnostics using medical image analysis, medical records analysis, and bioinformatics analysis supporting clinicians and researchers in fields of radiology, cardiology, oncology, pulmonology, neurology, hematology, endocrinology, otolaryngology, gynecology, obstetrics, urology, orthopedics, ophthalmology, pathology, pediatrics, physical medicine, surgery, emergency medicine, medical genetics and genomics, dermatology, family medicine, internal medicine, colorectal medicine, psychiatry, allergy and immunology, and preventive medicine; providing software as a service (SaaS) services featuring software for the analysis of medical data, namely, genomics data for use in identifying and predicting actionable biomarkers, neoantigens, and molecular data for developing paired diagnostics and therapeutics in the fields of radiology, cardiology, oncology, pulmonology, neurology, hematology, endocrinology, otolaryngology, gynecology, obstetrics, urology, orthopedics, ophthalmology, pathology, pediatrics, physical medicine, surgery, emergency medicine, medical genetics and genomics, dermatology, family medicine, internal medicine, colorectal medicine, psychiatry, allergy and immunology, and preventive medicine; providing software as a service (SaaS) services featuring software for executing preconfigured non-field specific machine learning and deep learning algorithms and processes for the purposes of uploading and managing data for the training of preconfigured data models implemented on a hosted software platform utilizing said machine learning and deep learning processes and for utilizing said trained data models for use in medical diagnostics, medical image analysis, medical screening, medical testing, DNA screening for medical purposes, and genetic testing for medical purposes; providing software as a service (SaaS) services featuring software for conducting natural language processing on medical records to transform unstructured data into structured data supporting clinical and research use; providing software as a service (SaaS) services featuring software for use in medical diagnostics, medical image analysis, medical screening, medical testing, DNA screening for medical purposes, and genetic testing for medical purposes, in particular for detecting and predicting significance of neoantigens and peptides on cells relevant to immunotherapy development

The English translation of "CURA" in the mark is "CARE".

Trademark Events

Jul 3, 2023

Abandonment Notice E-Mailed - No Use Statement Filed

Jul 3, 2023

Abandonment - No Use Statement Filed

Dec 6, 2022

Notice Of Approval Of Extension Request E-Mailed

Dec 5, 2022

Sou Extension 5 Granted

Dec 2, 2022

Sou Extension 5 Filed

Dec 2, 2022

Sou Teas Extension Received

May 20, 2022

Notice Of Approval Of Extension Request E-Mailed

May 18, 2022

Sou Extension 4 Granted

May 18, 2022

Sou Extension 4 Filed

May 18, 2022

Sou Teas Extension Received

Dec 2, 2021

Notice Of Approval Of Extension Request E-Mailed

Nov 30, 2021

Sou Extension 3 Granted

Nov 30, 2021

Sou Extension 3 Filed

Nov 30, 2021

Sou Teas Extension Received

May 26, 2021

Notice Of Approval Of Extension Request E-Mailed

May 25, 2021

Sou Extension 2 Granted

May 19, 2021

Sou Extension 2 Filed

May 25, 2021

Case Assigned To Intent To Use Paralegal

May 19, 2021

Sou Teas Extension Received

Feb 24, 2021

Automatic Update Of Assignment Of Ownership

Dec 4, 2020

Notice Of Approval Of Extension Request E-Mailed

Dec 2, 2020

Sou Extension 1 Granted

Dec 2, 2020

Sou Extension 1 Filed

Dec 2, 2020

Sou Teas Extension Received

Jun 2, 2020

Noa E-Mailed - Sou Required From Applicant

Apr 7, 2020

Official Gazette Publication Confirmation E-Mailed

Apr 7, 2020

Published For Opposition

Mar 18, 2020

Notification Of Notice Of Publication E-Mailed

Feb 18, 2020

Withdrawn From Pub - Og Review Query

Feb 6, 2020

Law Office Publication Review Completed

Feb 3, 2020

Approved For Pub - Principal Register

Jan 31, 2020

Teas/Email Correspondence Entered

Jan 30, 2020

Correspondence Received In Law Office

Jan 30, 2020

Teas Request For Reconsideration Received

Jan 3, 2020

Notification Of Final Refusal Emailed

Jan 3, 2020

Final Refusal E-Mailed

Jan 3, 2020

Final Refusal Written

Dec 18, 2019

Suspension Checked - To Attorney For Action

Jun 6, 2019

Report Completed Suspension Check Case Still Suspended

Jun 4, 2019

Assigned To Lie

Nov 2, 2018

Notification Of Letter Of Suspension E-Mailed

Nov 2, 2018

Letter Of Suspension E-Mailed

Nov 2, 2018

Suspension Letter Written

Oct 24, 2018

Teas/Email Correspondence Entered

Oct 23, 2018

Correspondence Received In Law Office

Oct 23, 2018

Teas Response To Suspension Inquiry Received

Aug 15, 2018

Notification Of Letter Of Suspension E-Mailed

Aug 15, 2018

Letter Of Suspension E-Mailed

Aug 15, 2018

Suspension Letter Written

Aug 14, 2018

Teas/Email Correspondence Entered

Aug 13, 2018

Correspondence Received In Law Office

Aug 13, 2018

Teas Response To Office Action Received

Jul 2, 2018

Notification Of Non-Final Action E-Mailed

Jul 2, 2018

Non-Final Action E-Mailed

Jul 2, 2018

Non-Final Action Written

Jun 26, 2018

Assigned To Examiner

Mar 22, 2018

New Application Office Supplied Data Entered

Mar 19, 2018

New Application Entered